Skip to content

Effects of Mental Stimulation in Patients With Mild Cognitive Impairment

A Theoretically Based Memory Training Intervention in Mild Cognitive Impairment

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01212692
Enrollment
63
Registered
2010-10-01
Start date
2010-10-31
Completion date
2014-06-30
Last updated
2015-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment (MCI)

Brief summary

The purpose of this study is to learn if activities that challenge the brain (mentally stimulating activities) can improve memory and other types of thinking in patients with Mild Cognitive Impairment. The study will compare the effects of different methods of mental stimulation.

Interventions

BEHAVIORALmentally stimulating activities

The study will compare the effects of different methods of mental stimulation. The intervention involves 6 classroom-style educational sessions and 10 mental stimulation studies involving computerized memory tasks.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* ≥ 50 years of age * meet criteria for amnestic-Mild Cognitive Impairment (MCI) * have capacity to give informed consent * have capacity to complete assessment measures

Exclusion criteria

* history of drug or alcohol dependence * severe psychiatric conditions associated with psychosis (e.g., schizophrenia) * recent stroke * clinical diagnosis of probable Alzheimer's Disease * history of seizure disorder, serious head trauma, or other medical, psychiatric, or neurological conditions associated with significant cognitive impairment (e.g., Parkinson's Disease, Korsakoff's, HIV) * current use of Alzheimer's Disease medications (e.g., cholinesterase inhibitors, memantine)

Design outcomes

Primary

MeasureTime frame
Self-Ordered Pointing Taskbaseline
Trail-Makingbaseline
Timed Instrumental Activities of Daily Livingbaseline
Rey Auditory Verbal Learning Testbaseline
Self-ordered pointing taskimmediately after the intervention

Secondary

MeasureTime frame
Neuropsychiatric Inventorybaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Recollection Taskbaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
N-Backbaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Clinical Dementia Rating Scalebaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Instrumental Activities of Daily Livingbaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Functional Capacities for Activities of Daily Livingbaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Multifactorial Memory Questionnairebaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Rivermead Behavioral Memory Testbaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Digit Symbol Substitution Testbaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Digit Spanbaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Verbal Fluency Testbaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention
Geriatric Depression Scalebaseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026